Research Article

Clinical Significance of Prothrombin Time in Cholangiocarcinoma Patients with Surgeries

Table 5

Log-rank test for overall survival (OS) and recurrence-free survival (RFS).

VariableCategoryP value of log-rank test for OS P value of log-rank test for RFS

Age<64/≥640.01460.0198
PLT, 109/L<258.67/≥258.670.08460.1154
PDW<17.99/>=17.990.72340.9862
MPV<12.46/>=12.460.38250.6952
LYM<1.5/>=1.50.06940.1348
NEU<7.12/>=7.120.54830.5754
PLR<240.18/>=240.180.81210.9405
NLR<6.17/>=6.170.01730.0621
APTT, s<30.8/≥30.80.57300.8356
PT, s<12.3/≥12.30.03730.0151
INR<1.07/≥1.070.03730.0151
FIB, g/l<4.49/≥4.490.19000.3878
TT, s<18.75/≥18.750.96890.7037
DD, ug/ml<1.14≥1.140.33560.1537
ALB<35/≥350.02900.0090
CRP<10/≥100.26570.2919
GPS0/1-20.48900.3282
CA199<37/>=370.26340.4389
CA125<36.49/≥36.490.89500.7607
CEA<5.1/≥5.10.34470.6197
DifferentiationMiddle-high/low0.00010.0001
stageI-II/III-IVA0.01260.0020

Obs, observation, PLT, platelet count, PDW, platelet distribution width, MPV, mean platelet volume, LYM, lymphocyte count NEU, neutrophil count, PLR, platelet-lymphocyte ratio, NLR, neutrophil-lymphocyte ratio, ALB, albumin, CRP, C-reactive protein, GPS, Glasgow Prognostic Score, APTT, activated partial thromboplastin time, PT, prothrombin time, INR, international normalized ratio, FIB, fibrinogen, TT, thrombin time, and DD: D-dimer.